U.S. Markets open in 4 hrs 12 mins

Trevena, Inc. (TRVN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1647+0.0077 (+4.90%)
At close: 04:00PM EDT
0.1650 +0.00 (+0.18%)
After hours: 07:33PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1570
Bid0.0000 x 2900
Ask0.0000 x 800
Day's Range0.1579 - 0.1699
52 Week Range0.1500 - 1.2000
Avg. Volume950,204
Market Cap27.096M
Beta (5Y Monthly)2.08
PE Ratio (TTM)N/A
EPS (TTM)-0.2300
Earnings DateNov 14, 2022 - Nov 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.17
  • GlobeNewswire

    Trevena to Participate at the H.C. Wainwright Annual Global Investment Conference

    CHESTERBROOK, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the Company will present a corporate overview at the H.C. Wainwright Annual Global Investment Conference being held in-person and virtually September 12- 14, 2022, in New York. Presentation DetailsDate: Monday, September 12, 2022Time: 4:30pm ETWeb

  • Zacks

    What Makes Trevena (TRVN) a New Buy Stock

    Trevena (TRVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Simply Wall St.

    We're A Little Worried About Trevena's (NASDAQ:TRVN) Cash Burn Rate

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...